Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment

By Weinreb Neal   Goldblatt Jack   Villalobos Jacobo   Charrow Joel   Cole J.   Kerstenetzky Marcelo   Dahl Stephan   Hollak Carla  

Journal of Inherited Metabolic Disease, Vol. 36, Iss. 3, 2013-05 ,pp. : 543-553

Springer Publishing Company

Access to resources Recommend Favorite

Clinical response to sildenafil in pulmonary hypertension associated with Gaucher disease

By Fernandes C.   Jardim C.   Carvalho L.   Farias A.   Filho M.   Souza R.  

Journal of Inherited Metabolic Disease, Vol. 28, Iss. 4, 2005-06 ,pp. : 603-605

Springer Publishing Company

Access to resources Recommend Favorite

Neuronopathic Gaucher disease: demographic and clinical features of 131 patients enrolled in the International Collaborative Gaucher Group Neurological Outcomes Subregistry

By Tylki-Szymańska Anna   Vellodi Ashok   El-Beshlawy Amal   Cole J.   Kolodny Edwin  

Journal of Inherited Metabolic Disease, Vol. 33, Iss. 4, 2010-08 ,pp. : 339-346

Springer Publishing Company

Access to resources Recommend Favorite

Gaucher disease: Variability in phenotype among siblings

By Amato D.   Stachiw T.   Clarke J. T. R.   Rivard G. E.  

Journal of Inherited Metabolic Disease, Vol. 27, Iss. 5, 2004-01 ,pp. : 659-669

Springer Publishing Company

Access to resources Recommend Favorite

High incidence of cholesterol gallstone disease in type 1 Gaucher disease: characterizing the biliary phenotype of type 1 Gaucher disease

By Taddei Tamar   Dziura James   Chen Shu   Yang Ruhua   Hyogo Hideyuki   Sullards Cameron   Cohen David   Pastores Gregory   Mistry Pramod  

Journal of Inherited Metabolic Disease, Vol. 33, Iss. 3, 2010-06 ,pp. : 291-300

Springer Publishing Company

Access to resources Recommend Favorite